Surgical versus non-surgical treatment of advanced intrahepatic cholangiocarcinoma: A comparative study
10.3760/cma.j.issn.1007-8118.2018.10.006
- VernacularTitle:手术与非手术治疗进展期肝内胆管癌疗效比较
- Author:
Jinlong GONG
1
;
Chuang PENG
;
Zheng TAN
;
Wenjia YUAN
;
Xiang HE
;
Bo JIANG
;
Jinshu WU
Author Information
1. 南华大学研究生院
- Keywords:
Intrahepatic cholangiocarcinoma,advanced stage;
Surgery;
Non-operation;
Therapeutic effectiveness
- From:
Chinese Journal of Hepatobiliary Surgery
2018;24(10):676-680
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the survival outcomes between operative versus non-operative treatment of advanced intrahepatic cholangiocarcinoma.Methods This is a retrospective study.The data from 122 patients with intrahepatic cholangiocarcinoma treated at the Hunan People's Hospital,the Hepatobiliary Hospital and the Oncology Department from January 2012 to October 2017 were retrospective studied.87 patients who underwent radical surgery (anatomical hepatectomy + regional lymph node dissection) formed the operation group;35 patients who were treated with chemotherapy and/or radiotherapy and/or biological targeted therapy formed the non-operative group.The general characteristics of the two groups including age,sex,ALT,AST,CA19-9,liver function,Child's classification,AJCC staging,tumor number,vascular (hepatic artery,portal vein) invasion and regional lymph node metastasis rates were compared.The overall survival of the two groups was compared.Results There were no significant differences in age,sex,ALT,AST,CA19-9,liver function,Child's classification,AJCC staging,tumor number,vascular (hepatic artery,portal vein) invasion and regional lymph node metastasis rates (P＞0.05).The overall survival of the operation group was significantly longer than that of the non-operative group (P＜0.05).The mean overall survival for the 2 groups of patients were 32 months and 15 months respectively.The 1-year survival rates were 74.8％ and 58.7％,and the 3 year survival rates were 42.4％ and 6.5％,respectively.The 5 years survival rates were 12.3％ and 0,respectively.Conclusion Operative treatment resulted in better median survival,as well as 1-,3-and 5-year survival rates than non-operative treatment for patients with advanced intrahepatic cholangiocarcinoma.
